Clinical Trial Update: Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 multicenter study of PM060184 in combination with gemcitabine in selected patients with advanced solid tumors completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PM060184

Snippet

Sponsor: PharmaMar | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2021-05-13